First, elevated ROS levels during ischemia increase AR activity, leading to an increase in the cytoplasmic NADH / NAD + ratio, which further induces the expression of HIF-1α and the transcription of the transferrin receptor (TfR) gene, triggering ATP depletion and tissue damage [169]. The gene discussed is TFRC; the disease is ischemia.